Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009

Philip J Smith1, Megan C Lindley, Lance E Rodewald

  • 1Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA 30333, USA. pzs6@cdc.gov

Insights

Children eligible for the Vaccines for Children (VFC) program, who often face socioeconomic disadvantages, achieved high vaccination coverage. This indicates successful public health interventions in protecting vulnerable populations against vaccine-preventable diseases.

Area of Science:

  • Public Health
  • Immunization
  • Pediatrics

Background:

  • Measles outbreaks in the late 1980s/early 1990s highlighted low national vaccination coverage and underimmunized populations in inner cities.
  • The Vaccines for Children (VFC) program was established to improve access to vaccines for eligible children.
  • Healthy People 2010 (HP 2010) set a 90% vaccination coverage objective for children.

Purpose of the Study:

  • To determine the percentage and demographics of children eligible for the VFC program in 2009.
  • To evaluate if HP 2010 vaccination coverage objectives were met for VFC-eligible children.

Main Methods:

  • Analysis of data from 16,967 children aged 19-35 months from the 2009 National Immunization Survey.
  • VFC eligibility criteria included Medicaid enrollment, lack of health insurance, specific race/ethnicity, or private insurance not covering all vaccine costs when vaccinated at specific health centers.

Main Results:

  • Approximately 49.7% of children aged 19-35 months were eligible for VFC vaccines.
  • VFC-eligible children were more likely to be Hispanic or non-Hispanic black, have mothers with lower educational attainment and single marital status, and live in low-income households.
  • Polio (91.7%) and hepatitis B (92.2%) vaccines met the HP 2010 90% coverage objective; measles-mumps-rubella (88.8%) and four others exceeded 80% coverage.

Conclusions:

  • Children with demographic profiles similar to those affected by past measles outbreaks are now VFC-eligible and receive vaccines at no cost.
  • High vaccination coverage levels have been achieved among VFC-eligible children, demonstrating the program's success in reaching vulnerable populations.
  • The VFC program plays a crucial role in ensuring equitable access to immunizations and achieving national health objectives.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...